174 related articles for article (PubMed ID: 8296795)
1. Erythropoietin in the treatment of delayed immune hemolysis of a major ABO-incompatible bone marrow transplant.
López J; Steegmann JL; Pérez G; Otero MJ; Berberana M; Cámara R; Lamana M; Fernández Villalta MJ; Fernández-Rañada JM
Am J Hematol; 1994 Mar; 45(3):237-9. PubMed ID: 8296795
[TBL] [Abstract][Full Text] [Related]
2. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE
Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749
[TBL] [Abstract][Full Text] [Related]
3. ABO-incompatible bone marrow transplantation.
Wiesneth M; Hertenstein B; Bunjes D; Schmeiser T; Maccari B; Northoff H; Laasch H; Heit W; Arnold R; Heimpel H
Beitr Infusionsther; 1992; 30():354-8. PubMed ID: 1284733
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
5. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin.
Fujisawa S; Maruta A; Sakai R; Taguchi J; Tomita N; Ogawa K; Kodama F; Takahashi K; Shibayama S; Kobayashi S; Ikuta K; Okubo T
Transpl Int; 1996; 9(5):506-8. PubMed ID: 8875795
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
Mair B; Benson K
Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
[TBL] [Abstract][Full Text] [Related]
7. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin.
Paltiel O; Cournoyer D; Rybka W
Transfusion; 1993 May; 33(5):418-21. PubMed ID: 8488547
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
9. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT.
Franchini M; de Gironcoli M; Gandini G; Vassanelli A; Rocca P; Benedetti F; Aprili G
Bone Marrow Transplant; 1998 May; 21(10):1071-3. PubMed ID: 9632284
[TBL] [Abstract][Full Text] [Related]
10. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation.
Salmon JP; Michaux S; Hermanne JP; Baudoux E; Gérard C; Sontag-Thull D; Fillet G; Beguin Y
Transfusion; 1999 Aug; 39(8):824-7. PubMed ID: 10504116
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow transplantation with major ABO incompatibility. Experience at the bone marrow transplantation unit of the Center of Lisbon at the IPOFG].
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1993 Feb; 6(2):79-81. PubMed ID: 8488766
[TBL] [Abstract][Full Text] [Related]
12. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
13. [Immunohematologic surveillance of patients treated with ABO incompatible bone marrow allografts].
Mizon P; Jouet JP; Vanhaesbroucke C; Villard F; Wibaut B; Goudemand J
Transfus Clin Biol; 1994; 1(4):271-7. PubMed ID: 7921283
[TBL] [Abstract][Full Text] [Related]
14. Hemolysis from ABO Incompatibility.
Simmons DP; Savage WJ
Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
[TBL] [Abstract][Full Text] [Related]
15. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
Yazer MH; Triulzi DJ
Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
[TBL] [Abstract][Full Text] [Related]
16. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.
Ohashi K; Akiyama H; Takamoto S; Tanikawa S; Sakamaki H; Onozawa Y
Bone Marrow Transplant; 1994 Mar; 13(3):335-6. PubMed ID: 8199576
[TBL] [Abstract][Full Text] [Related]
19. Clinical guide to ABO-incompatible allogeneic stem cell transplantation.
Booth GS; Gehrie EA; Bolan CD; Savani BN
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1152-8. PubMed ID: 23571461
[TBL] [Abstract][Full Text] [Related]
20. ABO-incompatible marrow transplants.
Bensinger WI; Buckner CD; Thomas ED; Clift RA
Transplantation; 1982 Apr; 33(4):427-9. PubMed ID: 7041368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
